Plato Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$153K Hold
1,790
– – 0.01% 412
2026
Q1
$162K Hold
1,790
– – 0.01% 415
2025
Q4
$162K Hold
1,790
– – 0.01% 400
2025
Q3
$175K Buy
1,790
+38
+2% +$3.77K 0.01% 399
2025
Q2
$159K Buy
1,752
+1
+0.1% +$97 0.01% 408
2025
Q1
$200K Hold
1,751
– – 0.02% 394
2024
Q4
$186K Hold
1,751
– – 0.01% 417
2024
Q3
$189K Buy
1,751
+9
+0.5% +$982 0.02% 388
2024
Q2
$189K Buy
1,742
+812
+87% +$95.7K 0.02% 338
2024
Q1
$123K Buy
930
+831
+839% +$104K 0.01% 339
2023
Q4
$12K Buy
+99
New +$11K 0.01% 358

Other funds holding ZBH

Plato Investment Management's ZBH Position: Q2 2026 in Review

Plato Investment Management held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 1,790 shares worth $153K. The position accounts for 0.01% of the portfolio, ranked #412.

Plato Investment Management first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $200K in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Plato Investment Management held 1,790 shares of Zimmer Biomet worth $153K as of Q2 2026.
  • Plato Investment Management left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up 0.01% of Plato Investment Management's portfolio in Q2 2026, its #412 holding.
  • Plato Investment Management first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
  • Plato Investment Management's Zimmer Biomet position peaked at $200K in Q1 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.